- Home
- STRM vs IGC Comparison
STRM vs IGC Comparison
Compare STRM & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRM
- IGC
- Stock Information
- Founded
- STRM 1989
- IGC 2005
- Country
- STRM United States
- IGC United States
- Employees
- STRM N/A
- IGC N/A
- Industry
- STRM EDP Services
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- STRM Technology
- IGC Health Care
- Exchange
- STRM Nasdaq
- IGC Nasdaq
- Market Cap
- STRM 15.4M
- IGC 18.0M
- IPO Year
- STRM 1996
- IGC N/A
- Fundamental
- Price
- STRM $2.33
- IGC $0.28
- Analyst Decision
- STRM
- IGC Strong Buy
- Analyst Count
- STRM 0
- IGC 2
- Target Price
- STRM N/A
- IGC $3.88
- AVG Volume (30 Days)
- STRM 10.0K
- IGC 241.5K
- Earning Date
- STRM 06-10-2025
- IGC 02-18-2025
- Dividend Yield
- STRM N/A
- IGC N/A
- EPS Growth
- STRM N/A
- IGC N/A
- EPS
- STRM N/A
- IGC N/A
- Revenue
- STRM $18,587,000.00
- IGC $1,236,000.00
- Revenue This Year
- STRM N/A
- IGC N/A
- Revenue Next Year
- STRM $4.04
- IGC $18.34
- P/E Ratio
- STRM N/A
- IGC N/A
- Revenue Growth
- STRM N/A
- IGC 1.65
- 52 Week Low
- STRM $1.82
- IGC $0.25
- 52 Week High
- STRM $9.75
- IGC $0.66
- Technical
- Relative Strength Index (RSI)
- STRM 39.16
- IGC 45.11
- Support Level
- STRM $2.24
- IGC $0.25
- Resistance Level
- STRM $2.75
- IGC $0.29
- Average True Range (ATR)
- STRM 0.29
- IGC 0.02
- MACD
- STRM 0.02
- IGC 0.00
- Stochastic Oscillator
- STRM 40.16
- IGC 60.00
About STRM Streamline Health Solutions Inc.
Streamline Health Solutions Inc provides transformational data-driven solutions for healthcare organizations. It provides computer software-based solutions through its looking glass platform. Its solutions include coding and CDI, coding audit, and financial management solutions. It offers various services, such as custom integration services, training services, electronic image conversion and database monitoring services. It sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.